
David Judson Browning MD
Retinal Disease
retina specialist-ophthalmologist at Charlotte Eye Ear Nose and Throat Associates
Join to view full profile
6035 Fairview RdCharlotte, NC 28210
Phone+1 704-295-3000
Fax+1 704-295-3186
Dr. Browning is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Miami/Jackson Health System/Bascom Palmer Eye InstituteResidency, Ophthalmology, 1985 - 1986
Duke University HospitalResidency, Ophthalmology, 1982 - 1985
Duke University HospitalInternship, Internal Medicine, 1981 - 1982
Duke University School of MedicineClass of 1981
Certifications & Licensure
NC State Medical License 1982 - 2027
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Medflow E HR, Medflow Holdings, LLC, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Medflow EHR, Medflow Holdings, LLC, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Medflow EHR, Medflow Holdings, LLC, 2012, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- 2 citationsNear Infrared Reflectance Imaging Changes in Acute Syphilitic Outer Retinitis.Alicia Chen, Ian Seddon, James Rhead, David J Browning
Ophthalmology. Retina. 2026-01-01 - 4 citationsThe Relationship of Hydroxychloroquine Retinopathy Progression to Stage at Cessation of Therapy.David J Browning, Donnie R Koonce, Akshay Mentreddy, Omar Punjabi
American Journal of Ophthalmology. 2025-09-01 - 1 citationsFoveal crack sign and macular pattern dystrophy.Rainer Rodriguez, David J Browning
International Journal of Retina and Vitreous. 2025-03-17
Press Mentions
Pain Control After Intravitreal Injection Using Topical Nepafenac 0.3% or Pressure Patching: A Randomized, Placebo-Controlled TrialApril 29th, 2020
Recapping Retina Subspecialty Day at the 2018 AAO Annual MeetingMarch 12th, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: